Abstract
Objectives Current estimates of the total number of cases of COVID-19 are largely based on previously-determined case fatality rates (CFRs). The background theory in this study is based on two factors: (1) There is no evidence that the CFR is fixed throughout time or place during an epidemic and (2) there is evidence that an increased viral load (density of infection) leads to more fatalities.
Study Design This study was done to look for relationships of the mortality rate (MR) presented as deaths/ million (M) population with both the total number of cases /(M) population (density of infection) and the CFR. We chose 31 countries with testing coverage levels of > 400,0000 tests /M and populations with greater than 1 million inhabitants.
Methods We used ANOVA regression analyses to test the associations.
Results The CRF is not a fixed ratio as it changes with a change in the MR. The COVID-19 deaths/million data were able to be used to calculate the total number of cases through the equation total deaths/M =0.006593 X (total cases1.016959) with a too high significant correlation between total deaths/1M and the total number of cases (P-value 0.0000).
A too high positive influence of the COVID-19 MR on the CFR (P-value = 0.0002) was also found by non-linear regression (power model) using the equation
CFR = (0.093200) X (total deaths/ M.)0.366580
Conclusions There is new evidence for using the MR to estimate the CFR and a total number of cases through uniform formulae. This is applicable during this pandemic and possibly for every epidemic. This evidence gives us an idea of the behavior of epidemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I used publically available data.Patients were not involved
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos